DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery

Summary

The primary objective of this study is to test the hypothesis that DYME is safe and effective as a drug to facilitate continuous curvilinear capsulorhexis (CCC) by selectively staining the anterior capsule. Secondary objectives are to compare the safety and effectiveness of DYME to that of a smaller dose of the same API.

Timeline

Start

2008-05

Primary completion

2008-09

Completion

2008-12

Outcome

Outcome not reported

Stopped: “Terminated due to reasons unrelated to safety”

Drugs

Indications